×
About 935 results

ALLMedicine™ Prolactinoma Center

Research & Reviews  338 results

Exercise Capacity and Physical Activity Level in Prolactinoma Patients
https://clinicaltrials.gov/ct2/show/NCT05236829

Aug 9th, 2022 - Prolactinoma is a pituitary adenoma caused by excessive prolactin secretion. More than 70% of patients are women. Many physiological conditions such as pregnancy, breastfeeding, breast stimulation, stress, exercise and sleep can also increase PRL ...

Prolactin at moderately increased levels confers a neuroprotective effect in non-secret...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348739
PloS One; Paul DA, Rodrigue A et. al.

Aug 4th, 2022 - Prolactin, a hormone synthesized by the anterior pituitary gland demonstrates promise as a neuroprotective agent, however, its role in humans and in vivo during injury is not fully understood. To investigate whether elevated levels of prolactin at...

Sex-specific Regulation of Prolactin Secretion by Pituitary Bradykinin Receptors.
https://doi.org/10.1210/endocr/bqac108
Endocrinology Abeledo-Machado A, Peña-Zanoni M et. al.

Jul 22nd, 2022 - Sex differences in the control of prolactin secretion are well documented. Sex-related differences in intrapituitary factors regulating lactotroph function have recently attracted attention. Sex differences in prolactinoma development are well doc...

Giant prolactinoma in children and adolescents: a single-center experience and systemat...
https://doi.org/10.1007/s11102-022-01250-y
Pituitary Kumar S, Sarathi V et. al.

Jul 20th, 2022 - Giant prolactinoma (GP) in childhood and adolescence is a rare entity with scarce literature. We aimed to describe clinical features, biochemistry, radiology, genetics, management, and outcome in pediatric (≤ 20 years) GP. Retrospective record rev...

β-Catenin is reduced in membranes of human prolactinoma cells and it is inhibited by te...
https://doi.org/10.3233/TUB-211500
Tumour Biology : the Journal of the International Society... Demarchi G, Valla S et. al.

Jul 12th, 2022 - Prolactinomas are the most frequent pituitary tumor subtype. Despite most of them respond to medical treatment, a proportion are resistant and become a challenge in clinical management. Wnt/β-Catenin pathway has been implicated in several cancers ...

see more →

Guidelines  1 results

Pituitary incidentaloma: an endocrine society clinical practice guideline.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393422
The Journal of Clinical Endocrinology and Metabolism; Freda PU, Beckers AM et. al.

Apr 9th, 2011 - The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-per...

see more →

Clinicaltrials.gov  18 results

Exercise Capacity and Physical Activity Level in Prolactinoma Patients
https://clinicaltrials.gov/ct2/show/NCT05236829

Aug 9th, 2022 - Prolactinoma is a pituitary adenoma caused by excessive prolactin secretion. More than 70% of patients are women. Many physiological conditions such as pregnancy, breastfeeding, breast stimulation, stress, exercise and sleep can also increase PRL ...

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
https://clinicaltrials.gov/ct2/show/NCT04158284

Mar 31st, 2022 - KRANIOPHARYNGEOM Registry 2019 will prospectively collect and descriptively analyse data on diagnostics, treatment, and follow-up of patients with craniopharyngioma. In continuation of preceding studies also patients with xanthogranuloma, meningio...

Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02544321

Sep 13th, 2021 - Type 1 diabetes (T1D) continues to be a disease plagued by hyperglycemia, insulin resistance (IR), and increased cardiovascular disease (CVD) despite advances in insulin delivery and glucose monitoring. Therefore new approaches are needed. Bromocr...

Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
https://clinicaltrials.gov/ct2/show/NCT03973450

Sep 8th, 2021 - Recent epidemiological studies indicate that clinically relevant PiT have a prevalence around 1%. The Neuromed Scientific Institute for Research and Cure (IRCCS) is a third referral center for the diagnosis and treatment of patients with hypothala...

Validation of a Quality of Life Metric "Prolac-10"
https://clinicaltrials.gov/ct2/show/NCT04106531

Jun 22nd, 2021 - This is a single-site validation study of a novel quality of life study for patients undergoing medical therapy for prolactinoma. Patients will be consented before starting their medical regimen and complete the "Prolac-10" questionnaire for basel...

see more →

News  13 results

Cabergoline Improves Metabolic Status in Hyperprolactinemia
https://www.medscape.com/viewarticle/974577

May 25th, 2022 - Researchers published the study covered in this summary on medRxiv.org as a preprint that has not yet been peer reviewed. Key Takeaways Patients with hyperprolactinemia secondary to a newly diagnosed prolactinoma who received 6 months of treatment...

Avoid pituitary pitfalls in hyperprolactinemia
https://www.mdedge.com/endocrinology/article/230804/pituitary-thyroid-adrenal-disorders/avoid-pituitary-pitfalls
Heidi Splete

Oct 28th, 2020 - When there is an abnormality in the pituitary gland, many potential areas could be affected because of the extent and range of hormones produced by the “master gland,” Ashlyn Smith, PA-C, of Endocrinology Associates, Scottsdale, Ariz. , said in a p.

Prolactin, the pituitary, and pregnancy: Where’s the balance?
https://www.mdedge.com/familymedicine/article/164370/pituitary-thyroid-adrenal-disorders/prolactin-pituitary-and-pregnancy/page/0/3
Clinical Endocrinology News;

Apr 26th, 2018 - What if the tumor grows in pregnancy? During pregnancy, high estrogen levels from the placenta can stimulate prolactinoma growth, and the dopamine agonist’s inhibitory effect is gone once that medication’s been stopped. This means that “We have bo.

Woman, 29, With Persistent Migraine
https://www.mdedge.com/clinicianreviews/article/72369/womens-health/grand-rounds-woman-29-persistent-migraine
Beth Gundy, PA-C, Laura M. Gunder-Mcclary, DHSC, MHE, PA-C

Feb 1st, 2012 - A 29-year-old woman with a history of frequent migraines presented to her primary care provider for a refill of medication. For the past two years she had been taking rizatriptan 10 mg, but with little relief.

Prolactinoma: A Case Study
https://www.mdedge.com/clinicianreviews/article/72153/endocrinology/prolactinoma-case-study
Sonia Bahroo, PA-C

Nov 1st, 2011 - A 42-year-old obese woman with type 2 diabetes, diabetic retinopathy, hypertension, and hirsutism presents to discuss an elevated prolactin level of 144. 8 ng/mL (normal range, 4.

see more →

Patient Education  4 results see all →